Elicio Therapeutics GAAP EPS of -$0.60 misses by $0.12
Source: SeekingAlpha
2025-11-13 17:08:58 ET
More on Elicio Therapeutics
- Elicio Therapeutics: Running On Fumes, But A Definitive Readout Appears Imminent
- Seeking Alpha’s Quant Rating on Elicio Therapeutics
- Historical earnings data for Elicio Therapeutics
- Financial information for Elicio Therapeutics
Read the full article on Seeking Alpha
For further details see:
Elicio Therapeutics GAAP EPS of -$0.60 misses by $0.12
Elicio Therapeutics Inc.
NASDAQ: ELTX
ELTX Trading
15.87% G/L:
$13.51 Last:
153,537 Volume:
$12.01 Open:
ELTX Latest News
February 25, 2026 08:00:00 am
Elicio Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference
December 11, 2025 08:00:00 am
Elicio Therapeutics Reports Antigen Spreading to Patient-Specific Neoantigens Beyond mKRAS in Ongoing Phase 2 AMPLIFY-7P Trial
November 19, 2025 08:00:00 am
Elicio Therapeutics Appoints Veteran CMC and Technical Operations Executive Marc J. Wolfgang as Chief Technology Officer
November 13, 2025 04:01:00 pm
Elicio Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
ELTX Stock Data
$152,158,789
11,312,219
1.64%
21
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
